News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
Patients who underwent SLCO1B1 testing were able to lower their cholesterol levels similarly to those who did not, indicating that testing does not cause harm.
Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients.
Exome array-wide association and rare variant-focused genome-wide association meta-analyses led to 87 rare variants with ties to one or more blood pressure traits.
A two-stage genome-wide association study and meta-analysis highlighted 11 novel and six known risk loci and made it possible to dig into the biology of intracranial aneurysm.
Using transcription data from cells and nuclei, the researchers uncovered heterogeneity within cardiac cells and mapped them to particular regions of the heart.
